The global laboratory information systems market was is valued at $1.8bn in 2017 and is expected to grow at a CAGR of 8.3% from 2018 to 2028. In 2017, the software segment held 71% of the global laboratory information systems market.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Laboratory Information Systems Market outlook from 2018-2028
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by delivery: • Web-based • On-Premise based • Cloud-based
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by application: • Clinical • Drug Discovery • Industrial
• Global Laboratory Information Systems Submarkets analysis and forecast from 2018-2028, by component: • Software • Hardware • Services
• This report provides individual revenue forecasts from 2018-2028 for these regional and national markets: • North America: US, Canada, Mexico • Europe: UK, Germany, France, Rest of Europe • Asia-Pacific: Japan, China, India, Rest of Asia-Pacific • Rest of the World (RoW)
• Our study discusses the selected leading companies that are the major players in the laboratory information systems market: • Abbott Laboratories • Cerner Corporation • Eclipsys Corporation • LabVantage Solutions, Inc. • LabWare, Inc. • McKesson Corporation • Medical Information Technology, Inc. • Thermo Fisher Scientific
• This report provides a Porter’s Five Forces Analysis of the global laboratory information systems market.
Visiongain’s study is intended for anyone requiring commercial analyses for the biologics market. You find data, trends and predictions.
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.
The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet
The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.
Rising epidemic potential, a growing emphasis on therapeutic vaccines, and new markets are projected to provide considerable growth prospects for vaccine providers.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
